EMAIL THIS PAGE TO A FRIEND

The Journal of neuroscience : the official journal of the Society for Neuroscience

Circuit formation and function in the olfactory bulb of mice with reduced spontaneous afferent activity.


PMID 25568110

Abstract

The type of neuronal activity required for circuit development is a matter of significant debate. We addressed this issue by analyzing the topographic organization of the olfactory bulb in transgenic mice engineered to have very little afferent spontaneous activity due to the overexpression of the inwardly rectifying potassium channel Kir2.1 in the olfactory sensory neurons (Kir2.1 mice). In these conditions, the topography of the olfactory bulb was unrefined. Odor-evoked responses were readily recorded in glomeruli with reduced spontaneous afferent activity, although the functional maps were coarser than in controls and contributed to altered olfactory discrimination behavior. In addition, overexpression of Kir2.1 in adults induced a regression of the already refined connectivity to an immature (i.e., coarser) status. Our data suggest that spontaneous activity plays a critical role not only in the development but also in the maintenance of the topography of the olfactory bulb and in sensory information processing.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

W269514
(±)-2-Methylbutyric acid, natural, ≥98%, FG
C5H10O2
W230707
(±)-Citronellal, ≥85%, FG
C10H18O
W230715
(±)-Citronellal, natural, ≥85%, FCC, FG
C10H18O
27470
(±)-Citronellal, ≥95.0% (GC)
C10H18O
72638
(±)-Citronellal, analytical standard
C10H18O
S9509
(±)-Sulfinpyrazone, analytical standard
C23H20N2O3S
27468
(−)-Citronellal, purum, ≥98.0% (sum of enantiomers, GC)
C10H18O
H3003
2-Heptanol, 98%
C7H16O
W328804
2-Heptanol, ≥97%
C7H16O
W269506
2-Methylbutyric acid, ≥98%, FG
C5H10O2
193070
2-Methylbutyric acid, 98%
C5H10O2
418099
Benzaldehyde, purified by redistillation, ≥99.5%
C7H6O
B1334
Benzaldehyde, ReagentPlus®, ≥99%
C7H6O
09143
Benzaldehyde, analytical standard
C7H6O
PHR1203
Benzaldehyde, Pharmaceutical Secondary Standard; Certified Reference Material
C7H6O
Y0001064
Benzaldehyde, European Pharmacopoeia (EP) Reference Standard
C7H6O
12010
Benzaldehyde, puriss. p.a., ≥99.0% (GC)
C7H6O
W212709
Benzaldehyde, ≥98%, FG, FCC
C7H6O
W212717
Benzaldehyde, natural, ≥98%, FCC, FG
C7H6O
ARK2163
Benzyl alcohol, PharmaGrade, USP/NF, Ph Eur, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production.
C7H8O
39971
Benzyl alcohol, certified reference material, TraceCERT®
C7H8O
08421
Benzyl alcohol, analytical standard
C7H8O
1061901
Benzyl alcohol, United States Pharmacopeia (USP) Reference Standard
C7H8O
13162
Benzyl alcohol, tested according to Ph.Eur.
C7H8O
PHR1019
Benzyl alcohol, Pharmaceutical Secondary Standard; Certified Reference Material
C7H8O
W213705
Benzyl alcohol, ≥99%, FCC, FG
C7H8O
W213713
Benzyl alcohol, natural, ≥98%, FG
C7H8O
Y0000167
Benzyl alcohol, European Pharmacopoeia (EP) Reference Standard
C7H8O
C95609
Cyclobutanecarboxylic acid, 98%
C5H8O2
C3350000
Cytarabine, European Pharmacopoeia (EP) Reference Standard
C9H13N3O5